Notch Signaling in Cancer: Rationale and Strategies for Targeting

Aisha Alketbi, Samir Attoub1

  • 1Department of Pharmacology & Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates. samir.attoub@uaeu.ac.ae.

Insights

The Notch signaling pathway regulates cell fate and stem cells. Suppressing this pathway offers targeted cancer therapy with fewer side effects than traditional treatments.

Area of Science:

  • Cell biology
  • Developmental biology
  • Cancer biology

Background:

  • The Notch signaling pathway is crucial for cell fate determination and stem cell maintenance.
  • Aberrant Notch signaling is implicated in various cancers, promoting proliferation and angiogenesis.
  • Targeting Notch signaling presents a promising strategy for cancer treatment.

Purpose of the Study:

  • To review the rationale for targeting the Notch signaling pathway in cancer.
  • To explore investigational strategies for blocking Notch signaling in cancer therapy.

Main Methods:

  • Literature review of Notch signaling in cancer.
  • Analysis of targeted therapeutic strategies.

Main Results:

  • Notch pathway dysregulation contributes to cancer development.
  • Targeted therapies inhibiting Notch signaling show potential advantages over conventional treatments.
  • Several investigational strategies exist to block the Notch pathway.

Conclusions:

  • Targeting the Notch signaling pathway is a rational approach for cancer treatment.
  • Investigational therapies offer a promising avenue for managing various cancers with potentially reduced toxicity.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K